Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON40328Active, not recruiting
Randomised, open-label trial of propofol and remifentanil (4 arms), sponsored by University Medical Center Groningen. Primary endpoints: Absolute hemodynamic and oxygenation measures, Change from baseline in hemodynamic and oxygenation measures and 2 more. Started Mar 2014; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON40328.